These days, everyone is being asked to do more with less.
The Food & Drug Administration is no exception. Congress is asking FDA hold more advisory committee reviews for new product applications, while at the same time forcing the agency to...
A year ago, Congress sent FDA two very clear, somewhat contradictory messages: Hold more advisory committee meetings, but without the use of many expert panelists used in the past. The result is a system that is stretched to the limits.
These days, everyone is being asked to do more with less.
The Food & Drug Administration is no exception. Congress is asking FDA hold more advisory committee reviews for new product applications, while at the same time forcing the agency to...